Drug-Eluting stents offer no advantage for A-Fib patients
(HealthDay) -- Drug-eluting stents (DESs) do not seem to offer advantages over bare-metal stents (BMSs) for patients with atrial fibrillation (AF) who undergo percutaneous coronary intervention (PCI) with stent implantation, ...
Jun 22, 2012
0
0